Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Commercial

VC Deals Analysis: 2017 Takes Medtech Venture Investing To New High

Venture-backed medical device and diagnostic companies enjoyed a boon year in 2017, when the annual intake of venture financing dollars hit a five-year high and surpassed the $6bn mark. Helping to give the year's total deal value a boost were several nine-figure deals, including a $900m Series B by Illumina spin-out Grail and others. Medtech Insight takes a look at the VC deal trends in 2017 and what could be ahead in 2018.

Financing StartUps and SMEs Deals


Set Alert for Companies

Latest From Companies

QUOTED. Jan. 17, 2018. Ariel Weinstein.

Check out what OCON Medical CEO Ariel Weinstein had to say about his company's efforts to leverage its "intrauterine ball" hormone-free contraceptive platform for future pipeline projects.
Commercial Companies

Start-Up Spotlight: OCON Medical Bets On A New 3D Copper Contraceptive Device

Israeli start-up OCON Medical is blazing a trail in the field of women's health with a new hormone-free contraceptive device. The company's IUB – intrauterine ball consists of copper pearls that prevent pregnancy locally within the uterus for five years.

Start-up Spotlight Commercial

QUOTED. Jan. 12, 2018. Raymond Cohen.

Check out who Axonics Modulation Technologies CEO Raymond Cohen says would make up his dream team to take the company’s technology from bench to market.
Quoted Business Strategies
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Medtech Money Flow: Weekly M&A And VC Deals, Jan, 8-14

In this new weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced between Jan. 8-14, 2018.

M & A Financing

Truffle Eyes A Dozen Investments With New BioMedtech Fund

Truffle Capital has raised $102m for its new institutional venture fund, nearly half of its $240m target, and is set to create and finance a dozen biotech and medtech companies with the capital.

Financing StartUps and SMEs

Illumina, Varian Among Flurry Of China Collabs

The ever-growing importance of the Chinese market and the increasing presence of Chinese players in the global medtech arena has not gone amiss in 2017, and the new year began with a flurry of announcements of further East-West partnerships being forged, including one by next-gen sequencing leader Illumina and by cancer therapy specialist Varian Medical Systems. Additionally, global investment firm Ally Bridge sealed a deal with LifeTech to co-invest in medtech companies looking to tackle China.

China Cancer
See All

Market Access

Set Alert for Market Access

Latest From Market Access

MRI And Cardiac-Rhythm Devices: A Match Made In Medicare

A proposed coverage policy from the US Centers for Medicare and Medicaid Services would not only cover magnetic resonance imaging for patients with an implanted cardiac rhythm management device with an FDA-approved indication for MRI-compatibility, but will also cover MRI in patients with devices without that FDA labeling in certain circumstances.

United States Clinical Trials

Lingering Debt And New E-Procurement System Await Turkish Medtech

2017 saw developments that were beneficial to the Turkish medtech industry, like the continued progress of the billion-dollar City Hospitals project, but also initiatives such as forthcoming Online Health System Market that will have a mixed impact on industry players. Additionally, the year also saw medtech suppliers increasingly frustrated by the growing debt that is owed to them by Turkey's hospitals, an issue that remains unresolved. This article give an overview of the Turkish medtech market in 2017 and developments to look out for this year.

Turkey Market Access

Successful Selling: Conquering The West – How European Medtech Firms Can Penetrate The US

In spite of the increased attention medtech companies have been paying over the last few years to the emerging countries, the US remains undeniably the biggest market for medical devices. Yet, this market continues to leave many European medtech firms stumped. In this article, the second in a four-part series focused on sales strategies, Brian Chapman and Lukas Grabner of global sales and marketing strategy consulting firm ZS list the key reasons why European companies are struggling to conquer the US and how they can overcome these hurdles.

United States Market Access
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

QUOTED. Jan. 4, 2018. Justin Barad.

Check out what Osso VR CEO – and pediatric orthopedic surgeon – Justin Barad had to say about how patient preference could boost interest in minimally invasive knee and hip arthroplasties.
Quoted Orthopedics

EU Ortho Close-Up: Rising, But Varying Orthopedic/Spinal Opportunities In 5 European Markets

A rising and more active aging population, and a growing incidence of osteoporosis fractures and back pain – as well as other spine-related issues – are paving the way for companies to bring innovative devices into the hands of orthopedic and spinal surgeons in Spain, Italy, Germany, the UK and France. In this feature, we take a closer look at the prevailing surgical approaches and techniques for selected fracture fixation, spinal surgery procedures, joint replacement, and arthroscopy procedures in each of the five major EU countries, as outlined in a new Meddevicetracker report. We also take a deep dive into the various growth opportunities of select procedures in each EU market and discuss trends.

Surgical Procedures Orthopedics

QUOTED. Dec. 22, 2017. Andrew Thompson.

Check out what Proteus Digital Health's Andrew Thompson has to say about how digital medicines can help ensure better health decisions and outcomes for patients.
Quoted Commercial
See All


Set Alert for Appointments

Latest From Appointments

Philips' Ultrasound Head Takes Over North Am Unit

Vitor Rocha, head of Philips' global ultrasound business, has taken over from Brent Shafer as CEO of Philips North America.

Appointments Companies

Roche Exec Heads Grail As First Cancer Test Launch Looms

Illumina spin-out Grail has started the new year with a new CEO at the helm. Jennifer Cook joins the firm from Swiss pharma and diagnostics giant Roche.

In Vitro Diagnostics Cancer

Zimmer Biomet Lands Medtronic Exec As Its New CEO

The orthopedic giant hired a well-respected medtech industry veteran as its new CEO, leading to some seat-jumping within Medtronic's executive ranks.

Appointments Commercial
See All